 |
|
|
|
|||
  |
||||||
 |
   
  |
|||||
|
David Harmon, MD
Telephone 617-726-8748 Office Address Massachusetts General Hospital Cancer Center Center for Sarcoma and Connective Tissue Oncology 55 Fruit Street, Yawkey 7 Boston, MA 02114 |
 |
|||||
|
 Orthopaedic Oncology Francis Hornicek, MD, PhD Director & Surgeon Frank X. Pedlow, Jr. MD Surgeon Kevin Raskin, MD Surgeon Joseph Schwab, MD Surgeon Dempsey Springfield, MD Surgeon Nursing Al Ferreira, RN Nurse Coordinator Anne Fiore, NP Nurse Practitioner Radiation Oncology Yen-Lin Chen, MD Radiation Oncologist Thomas DeLaney, MD Radiation Oncologist Norbert Liebsch, MD, PhD Radiation Oncologist Medical Oncology Edwin Choy, MD, PhD Medical Oncologist David Harmon, MD Medical Oncologist Scott Plotkin, MD, PhD Medical Oncologist Judianne Henderson, NP Nurse Practitioner NeuroSurgery Frederick Barker, MD Neurosurgeon Lawrence Borges, MD Neurosurgeon William Curry, MD Neurosurgeon Plastic Surgery William Gerald Austen, MD Plastic Surgeon Eric Liao, MD, PhD Plastic Surgeon Radiology Susan Kattapuram, MD Radiologist Daniel Rosenthal, MD Radiologist Pathology G. Petur Nielsen, MD Pathologist Andrew Rosenberg, MD Pathologist ENT Stacey Gray, MD Otolaryngologist Eric Holbrook, MD ENT Surgeon Derrick Lin, MD ENT Surgeon James Rocco, MD, PhD ENT Surgeon Research Francis Hornicek, MD, PhD Co-Director Ramnik Xavier, MD Co-Director Zhenfeng Duan, MD, PhD Joseph Schwab, MD Surgeon Click here for the Contact Us page
|
|
"Although we still lack medicines that can be counted on to shrink or slow the growth of chordomas, we are following a variety of exciting leads. Our goal is to keep studying the biology of chordomas to identify targets for chemotherapy and then to make clinical trials available to those who need more than surgery and radiation. " David Harmon, MD
Education Postdoctoral Training Board Certification Academic Appointments Publications Mankin HJ, Hornicek FJ, Rosenberg AE, Harmon DC, Gebhardt MC. Survival data for 648 patients with osteosarcoma treated at one institution. Clin Orthop Relat Res. 2004 Dec;(429):286-91. DeLaney TF, Spiro IJ, Suit HD, Gebhardt MC, Hornicek FJ, Mankin HJ, Rosenberg AL, Rosenthal DI, Miryousefi F, Ancukiewicz M, Harmon DC. Neoadjuvant chemotherapy and radiotherapy for large extremity soft-tissue sarcomas. Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1117-27. Fidias P, Spiro I, Sobczak ML, Nielsen GP, Ruffolo EF, Mankin H, Suit HD, Harmon DC. Long-term results of combined modality therapy in primary bone lymphomas. Int J Radiat Oncol Biol Phys. 1999 Dec 1;45(5):1213-8. As a medical oncologist, Dr. Harmon has focused on the care of patients with bone and soft tissue tumors. Because the specialized surgical and radiotherapy expertise of MGH draws patients from all over the world, his clinical practice has included many otherwise rare patients with unresectable or metastatic chordoma. He has long seen the need for effective new therapies and has participated in clinical trials to develop chemotherapies. Now a critical mass of researchers has directed their attention towards understanding the basic biology of chordoma and to finding new targets for therapy. Collaborative efforts with other centers are developing a series of clinical trials. Together with Dr. Choy and the rest of the clinical research team he will push these efforts to find cures.
|
||||
| Home | Copyright © 2009 The Massachusetts General Hospital |
Site Map | ||||
